GRAIL, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
GRAIL, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does GRAIL, Inc. do? Business model and key facts
Get the full picture of GRAIL, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Employees (FY): 1000
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Stocks related to GRAIL, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting GRAIL, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
GRAIL, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
